This is the authors' abstract. We don't add key points for this paper.
The 24-week treatment with oral semaglutide ameliorated glycemic control with reduction of body fat but not muscle mass in Japanese patients with type 2 diabetes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Uchiyama et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: